FAB-117-HC

N/A

Report date: 2024/11/09 20:00:08

Base Information

Drug NameFAB-117-HC
Drug Alias NameNeuroSaveFIB-117FAB-117-HCFAB-117
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFerrerHistocell Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHistocell SlFerrer Internacional Sa
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A